These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3383719)

  • 1. Comparison between serum isonicotinic acid hydrazide (INH) levels and urinary sulfadimidine (sulfamethazine) acetylation as predictors of INH acetylator status.
    Seth V; Seth SD; Beotra A; Singh U
    Dev Pharmacol Ther; 1988; 11(1):32-6. PubMed ID: 3383719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.
    Singh SP; Pande JN; Khilnani GC; Kailash S
    Indian J Chest Dis Allied Sci; 1996; 38(1):5-11. PubMed ID: 16892742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of concomitant isoniazid administration on determination of acetylator phenotype by sulphadimidine.
    Zysset T; Peretti E
    Eur J Clin Pharmacol; 1986; 30(4):463-6. PubMed ID: 3743623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoniazid acetylation phenotyping in Saudi Arabs.
    Matar KM; Mayet AY; Ayoola EA; Bawazir SA; Al-Faleh FZ; Al-Wazzan A
    J Clin Pharm Ther; 2004 Oct; 29(5):443-7. PubMed ID: 15482388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.
    Horai Y; Ishizaki T; Sasaki T; Koya G; Matsuyama K; Iguchi S
    Br J Clin Pharmacol; 1982 Mar; 13(3):361-74. PubMed ID: 7059436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylation polymorphism and leprosy.
    Eze LC; Okpogba AN; Ogan AU
    Biochem Genet; 1990 Feb; 28(1-2):1-7. PubMed ID: 2344344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoniazid Acetylation Phenotyping in the Japanese: The Molar Metabolic Ratio INH/AcINH.
    Kohno H; Kubo H; Takada A; Mori M; Arias TD
    Am J Ther; 1996 Jan; 3(1):74-78. PubMed ID: 11856999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the acetylator phenotype using matrix isoniazid.
    Ellard GA; Gammon PT; Titinen H
    Tubercle; 1975 Sep; 56(3):203-9. PubMed ID: 1216339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoniazid pharmacokinetics in children according to acetylator phenotype.
    Rey E; Gendrel D; Treluyer JM; Tran A; Pariente-Khayat A; d'Athis P; Pons G
    Fundam Clin Pharmacol; 2001 Oct; 15(5):355-9. PubMed ID: 11903505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acetylation phenotype of isoniazid in Morocco. Preliminary study of 100 cases].
    Bouayad Z; Chevalier B; Maurin R; Bartal M
    Rev Fr Mal Respir; 1982; 10(6):401-7. PubMed ID: 7163595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylation of sulfamethazine in a Nigerian population.
    Eze LC; Obidoa O
    Biochem Genet; 1978 Dec; 16(11-12):1073-7. PubMed ID: 751642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification of children as slow or rapid acetylators based on concentrations of isoniazid in saliva following oral administration of body-weight and surface-area-related dosages of the drug.
    Sarma GR; Kailasam S; Datta M; Loganathan GK; Rahman F; Narayana AS
    Indian Pediatr; 1990 Feb; 27(2):134-42. PubMed ID: 2361757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of the acetylator phenotype in Moroccan tuberculosis patients using isoniazid as metabolic probe.
    Aït Moussa L; Khassouani CE; Hüe B; Jana M; Bégaud B; Soulaymani R
    Int J Clin Pharmacol Ther; 2002 Dec; 40(12):548-53. PubMed ID: 12503812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis].
    Ellard GA
    Rev Mal Respir; 1984; 1(4):207-19. PubMed ID: 6505358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylation of procainamide in man and its relationship to isonicotinic acid hydrazide acetylation phenotype.
    Gibson TP; Matusik J; Matusik E; Nelson HA; Wilkinson J; Briggs WA
    Clin Pharmacol Ther; 1975 Apr; 17(4):395-9. PubMed ID: 1122681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoniazid acetylator status of Black South African tuberculosis patients.
    Bach PH; Higgins-Opitz SB; Bima B; Leary WP
    S Afr Med J; 1976 Jul; 50(29):1132-4. PubMed ID: 959925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bioavailability of isoniazid in healthy volunteers--fast and slow INH acetylators].
    Augustynowicz-Kopeć E; Zwolska Z; Niemirowska-Mikulska H
    Pneumonol Alergol Pol; 2002; 70(3-4):167-79. PubMed ID: 12271964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of human lymphocyte N-acetyltransferase and its relationship to the isoniazid acetylator polymorphism.
    McQueen CA; Weber WW
    Biochem Genet; 1980 Oct; 18(9-10):889-904. PubMed ID: 7225085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.
    Ylitalo P; Auterinen L; Marttinen A; Koivula T
    Int J Clin Pharmacol Res; 1984; 4(2):141-4. PubMed ID: 6469440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple method for determining acetylator phenotype using isoniazid.
    Hutchings A; Routledge PA
    Br J Clin Pharmacol; 1986 Sep; 22(3):343-5. PubMed ID: 3768246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.